Pharma 4.0 and the Digitalisation of Manufacturing

As the pharma industry seeks ways of streamlining its manufacturing processes while adhering to stringent regulatory requirements, this podcast addresses Pharma 4.0 is and why it is so important.What are the main challenges for pharma manufacturers during the digital era?Have stringent regulatory requirements and emphasis on compliance stifled/slowed innovation and continuous improvement in pharmaceutical manufacturing?What digital tools are currently available to pharma/biotech manufacturers to improve their processes?What can manufacturers do to utilise digital solutions without compromising the regulatory requirements?How will the implementation of Pharma 4.0 impact human workforces?About the Speaker:Thomas Halfmann, Global Head Production IT, NNITThomas Halfmann is an advocate of digitalization in Life Sciences Production and Supply Chain with more than 25 years of experience in manufacturing IT and automation in the life sciences industry. After various management positions at Novartis, including Head Global Project Office, Global MES Program Manager and Global Head Biopharmaceutical Operations IT, Thomas co-founded the international life sciences consulting group HGP in 2008. HGP had offices in Switzerland, Germany, Singapore, Poland and Indonesia and was acquired by NNIT in 2019. Since October 2019 Thomas is the Global Head Production IT for NNIT. He is a frequent speaker at international life sciences conferences, author of various publications and member of various industry associations like ISPE and OPC Foundation where he is one of the Directors of the OPEN-SCS Working Group since 2018.